RMD
ResMed·NYSE
--
--(--)
--
--(--)
6.23 / 10
Outperform
With a fund flow rating of 7.92/10, the stock shows robust fund flow characteristics. Supportive momentum from overall, block, Small, Medium, Large, and Extra-large trends is partially offset by concerning no significant trends patterns, pointing to positive capital flow trajectory. Analyst consensus points to cautiously optimistic analyst perspective with balanced view. Distribution analysis: Strong Buy(20.0%), Buy(20.0%), Neutral(60.0%) among 5 research opinions, supported by 4.54 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
20%
Buy
20%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionPiper Sandler
Times predicted3
Historical Win Rate100.0%
Is money flowing into or out of RMD?
- RMD holds a Bearish analyst rating, with 20% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.23/10 (Outperform).
